Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05217342Phase 4Unknown
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Marmara University. Primary endpoint: Composite of all-cause mortality, all-cause hospitalization, and all-cause emergency department visits at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05217342.